4//SEC Filing
Sablich Kim 4
Accession 0001765581-23-000036
CIK 0001232524other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:10 PM ET
Size
7.1 KB
Accession
0001765581-23-000036
Insider Transaction Report
Form 4
Sablich Kim
EVP & GM, North America
Transactions
- Sale
Ordinary Shares
2023-03-08$140.19/sh−1,261$176,780→ 30,560 total - Sale
Ordinary Shares
2023-03-08$139.42/sh−1,752$244,264→ 31,821 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.95 to $139.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $139.97 to $140.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001758790
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 6:10 PM ET
- Size
- 7.1 KB